Evidence map›Paper›PMID 31189404›Full record

ArticleBioengineered2019

Targeting XIST induced apoptosis of human osteosarcoma cells by activation of NF-kB/PUMA signal.

Weiliang Gao, Jisheng Gao, Longying Chen, Yande Ren, Jinfeng Ma

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  4. Review
  5. Potential roles of lncRNA-XIST/miRNAs/mRNAs in human cancer cells.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  6. Review
  7. Article
  8. Review
  9. Long non-coding RNA XIST: a novel oncogene in multiple cancers.Molecular medicine (Cambridge, Mass.) · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Weiliang Gaoa Department of Spine Surgery , The 107 Hospital of the People's Liberation Army , Yantai , Shandong , China.ORCID 0000-0003-2026-6271
Jisheng Gaoa Department of Spine Surgery , The 107 Hospital of the People's Liberation Army , Yantai , Shandong , China.
Longying Chenb Department of Orthopedics , Linyi Central Hospital , Linyi , Shangdong , China.
Yande Renc Department of Radiology , The affiliated hospital of Qingdao University , Qingdao , Shandong , China.
Jinfeng Mad Department of Spine Surgery , The affiliated hospital of Qingdao University , Qingdao , Shandong , China.
People's Liberation Army 401 Hospital · CNQingdao University · CNLinyi People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The long noncoding RNA X-inactive specific transcript (

Indexed as

ApoptosisApoptosis Regulatory ProteinsCell Line, TumorHumansNF-kappa BOsteosarcomaProto-Oncogene ProteinsRNA, Long NoncodingRNA, Small InterferingSignal TransductionTumor Suppressor Protein p53Apoptosis Regulatory ProteinsBBC3 protein, humanNF-kappa BProto-Oncogene ProteinsRNA, Long NoncodingRNA, Small InterferingTP53 protein, humanTumor Suppressor Protein p53XIST non-coding RNAApoptosislong noncoding RNA X-inactive specific transcriptnuclear factor-kappa BOsteosarcomap53 upregulated modulator of apoptosis

Identifiers

PMID31189404
PMCPMC6592364
OpenAlexW2949234644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.